易方达医药生物股票A(010387)资产负债表
|
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
资产 |
银行存款 |
- |
- |
- |
184,567,091.88 |
结算备付金 |
8,165,088.34 |
2,255,990.71 |
2,805,126.09 |
4,800,364.20 |
存出保证金 |
330,710.82 |
248,010.88 |
211,880.05 |
546,521.65 |
交易性金融资产 |
2,911,745,668.13 |
2,874,084,618.64 |
3,440,939,765.42 |
2,521,094,858.98 |
其中:股票投资 |
2,911,745,668.13 |
2,870,873,883.26 |
3,439,204,658.95 |
2,519,479,876.63 |
债券投资 |
- |
3,210,735.38 |
1,735,106.47 |
1,614,982.35 |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
70,136,247.52 |
9,213,684.15 |
7,134,670.43 |
3,024,892.46 |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
1,792,375.78 |
- |
154,455.90 |
应收申购款 |
3,518,647.01 |
22,328,144.69 |
4,814,806.80 |
1,718,485.49 |
其他资产 |
- |
- |
- |
- |
资产总计 |
3,305,330,671.64 |
3,139,509,003.18 |
3,682,268,760.76 |
2,715,906,670.56 |
负 债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
12,433,872.66 |
5,398,901.45 |
7,698.43 |
8,094,431.08 |
应付赎回款 |
160,772,901.95 |
6,318,103.33 |
26,143,485.49 |
3,255,020.79 |
应付管理人报酬 |
3,503,832.55 |
3,186,995.83 |
3,736,206.76 |
3,487,292.67 |
应付托管费 |
583,972.10 |
531,165.93 |
622,701.14 |
581,215.45 |
应付销售服务费 |
447,465.20 |
390,276.22 |
473,972.94 |
230,119.79 |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
- |
7.39 |
3.45 |
28.22 |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
1,397,672.15 |
896,830.77 |
1,604,763.85 |
1,472,787.94 |
负债合计 |
179,139,716.61 |
16,722,280.92 |
32,588,832.06 |
17,120,895.94 |
所有者权益 |
实收基金 |
5,302,435,396.02 |
5,396,093,559.89 |
5,573,837,252.50 |
4,384,352,606.99 |
未分配利润 |
-2,176,244,440.99 |
-2,273,306,837.63 |
-1,924,157,323.80 |
-1,685,566,832.37 |
所有者权益合计 |
3,126,190,955.03 |
3,122,786,722.26 |
3,649,679,928.70 |
2,698,785,774.62 |
负债及所有者权益总计 |
3,305,330,671.64 |
3,139,509,003.18 |
3,682,268,760.76 |
2,715,906,670.56 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年